Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protons | 6 | 2017 | 80 | 0.760 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2017 | 4 | 0.440 |
Why?
|
| Space Flight | 1 | 2009 | 9 | 0.370 |
Why?
|
| Bacteria | 2 | 2010 | 245 | 0.360 |
Why?
|
| Weightlessness | 1 | 2009 | 14 | 0.360 |
Why?
|
| DNA Repair | 1 | 2010 | 181 | 0.350 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 968 | 0.330 |
Why?
|
| Gene Expression Profiling | 4 | 2011 | 600 | 0.300 |
Why?
|
| DNA Damage | 3 | 2017 | 341 | 0.290 |
Why?
|
| Biosensing Techniques | 4 | 2011 | 81 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 7 | 2017 | 649 | 0.230 |
Why?
|
| Nanotubes, Carbon | 3 | 2009 | 67 | 0.220 |
Why?
|
| Apoptosis | 4 | 2017 | 1317 | 0.220 |
Why?
|
| Yersinia pestis | 2 | 2011 | 35 | 0.200 |
Why?
|
| Conductometry | 2 | 2010 | 6 | 0.190 |
Why?
|
| Mycotoxins | 2 | 2010 | 12 | 0.190 |
Why?
|
| Food Analysis | 2 | 2010 | 30 | 0.190 |
Why?
|
| Food Contamination | 2 | 2010 | 55 | 0.180 |
Why?
|
| Reactive Oxygen Species | 6 | 2011 | 416 | 0.180 |
Why?
|
| Oxidative Stress | 4 | 2010 | 874 | 0.170 |
Why?
|
| Brain | 3 | 2011 | 1268 | 0.170 |
Why?
|
| Whole-Body Irradiation | 1 | 2017 | 8 | 0.160 |
Why?
|
| Lung | 2 | 2010 | 413 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 115 | 0.150 |
Why?
|
| Animals | 12 | 2017 | 14307 | 0.140 |
Why?
|
| Keratinocytes | 2 | 2007 | 65 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2009 | 193 | 0.140 |
Why?
|
| Mice | 8 | 2017 | 5668 | 0.130 |
Why?
|
| Virulence | 3 | 2010 | 221 | 0.130 |
Why?
|
| Antioxidants | 4 | 2011 | 386 | 0.130 |
Why?
|
| Nanotechnology | 3 | 2011 | 150 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2011 | 23 | 0.100 |
Why?
|
| Plague Vaccine | 1 | 2011 | 4 | 0.100 |
Why?
|
| Electricity | 1 | 2011 | 9 | 0.100 |
Why?
|
| Thrombin | 1 | 2011 | 24 | 0.100 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 28 | 0.100 |
Why?
|
| Plague | 1 | 2011 | 24 | 0.100 |
Why?
|
| Electrolytes | 1 | 2011 | 25 | 0.100 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2010 | 3 | 0.100 |
Why?
|
| Endonucleases | 1 | 2010 | 18 | 0.100 |
Why?
|
| Microchemistry | 1 | 2010 | 10 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2010 | 29 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 104 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 72 | 0.100 |
Why?
|
| Metals | 1 | 2011 | 95 | 0.100 |
Why?
|
| Oxidants | 1 | 2010 | 43 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2010 | 44 | 0.090 |
Why?
|
| Polymers | 1 | 2011 | 117 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 110 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2010 | 366 | 0.090 |
Why?
|
| Weightlessness Simulation | 1 | 2009 | 15 | 0.090 |
Why?
|
| Magnetics | 1 | 2009 | 36 | 0.090 |
Why?
|
| Immunoassay | 1 | 2009 | 57 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 184 | 0.090 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 51 | 0.080 |
Why?
|
| Nanostructures | 1 | 2010 | 133 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 220 | 0.080 |
Why?
|
| DNA Primers | 2 | 2006 | 269 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 490 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 550 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 298 | 0.080 |
Why?
|
| Foreskin | 1 | 2007 | 4 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 522 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1152 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2009 | 436 | 0.070 |
Why?
|
| Equipment Design | 3 | 2011 | 127 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 520 | 0.070 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 38 | 0.070 |
Why?
|
| Male | 7 | 2017 | 18870 | 0.070 |
Why?
|
| DNA Fragmentation | 3 | 2010 | 91 | 0.070 |
Why?
|
| Glutathione | 3 | 2011 | 160 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2006 | 125 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2017 | 37 | 0.060 |
Why?
|
| DNA, Fungal | 1 | 2004 | 40 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 455 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2005 | 306 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2006 | 316 | 0.050 |
Why?
|
| Humans | 9 | 2011 | 34853 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 430 | 0.050 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 42 | 0.050 |
Why?
|
| Lipid Peroxidation | 2 | 2011 | 131 | 0.050 |
Why?
|
| Caspase 8 | 2 | 2010 | 31 | 0.050 |
Why?
|
| Superoxide Dismutase | 2 | 2011 | 149 | 0.050 |
Why?
|
| Cell Line | 3 | 2009 | 1289 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2010 | 194 | 0.040 |
Why?
|
| Intestines | 1 | 2017 | 63 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2008 | 67 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 984 | 0.040 |
Why?
|
| Cell Survival | 2 | 2010 | 818 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2009 | 423 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 555 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 1681 | 0.030 |
Why?
|
| Base Sequence | 2 | 2006 | 932 | 0.030 |
Why?
|
| DNA | 2 | 2006 | 549 | 0.030 |
Why?
|
| Rats | 2 | 2010 | 3261 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2011 | 1802 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2011 | 25 | 0.030 |
Why?
|
| Bioterrorism | 1 | 2011 | 18 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 19 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 22 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2011 | 141 | 0.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 28 | 0.020 |
Why?
|
| Chitosan | 1 | 2011 | 36 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2010 | 50 | 0.020 |
Why?
|
| Testis | 1 | 2011 | 185 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 342 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2009 | 23 | 0.020 |
Why?
|
| Formazans | 1 | 2009 | 5 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 36 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 145 | 0.020 |
Why?
|
| Free Radicals | 1 | 2009 | 72 | 0.020 |
Why?
|
| Hela Cells | 1 | 2010 | 344 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 126 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 260 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2008 | 21 | 0.020 |
Why?
|
| Suspensions | 1 | 2008 | 42 | 0.020 |
Why?
|
| Microspheres | 1 | 2008 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 901 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 196 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 351 | 0.020 |
Why?
|
| Dimethylformamide | 1 | 2007 | 7 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2011 | 371 | 0.020 |
Why?
|
| Solvents | 1 | 2007 | 93 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1442 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1530 | 0.020 |
Why?
|
| DNA Probes, HPV | 1 | 2006 | 3 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 38 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 650 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2005 | 40 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 605 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2004 | 38 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2006 | 295 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 162 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 639 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 156 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 641 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 1149 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 1023 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 3414 | 0.010 |
Why?
|
| Female | 1 | 2006 | 19873 | 0.000 |
Why?
|